Disentangling Diagnosis and Management of Fibromyalgia
- Author:
Ji-Hyoun KANG
1
;
Sung-Eun CHOI
;
Dong-Jin PARK
;
Shin-Seok LEE
Author Information
- Publication Type:Review Article
- From:Journal of Rheumatic Diseases 2022;29(1):4-13
- CountryRepublic of Korea
- Language:English
- Abstract: Fibromyalgia (FM) is a chronic pain condition characterized by widespread pain accompanied by symptoms such as fatigue, sleep disturbance, cognitive dysfunction, and mood disorder. The pathophysiology of FM has been unclear, leading to inconsistent diagnosis and ineffective management. Several diagnostic criteria for FM have been proposed in recent years, including the revised 2016 American College of Rheumatology (ACR) criteria, the criteria of the ACTTION-American Pain Society Pain Taxonomy (AAPT) group, and the modified 2019 Fibromyalgia Assessment Status (FAS) criteria. Despite the appearance of newer criteria for FM diagnosis, the 2016 ACR criteria demonstrate the best performance. Many randomized controlled studies and systematic reviews have shown the therapeutic efficacies of pharmacological and non-pharmacological treatments of FM. Nevertheless, further research is needed to develop better treatment options.
